Cargando…
Women’s cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics
Over the last two decades, discoveries related to the breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2) have profoundly changed our understanding and management of hereditary breast and ovarian cancers. The concept of synthetic lethality, which arises when cells become vulnerable to a com...
Autores principales: | Murthy, Pooja, Muggia, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411414/ https://www.ncbi.nlm.nih.gov/pubmed/30915162 http://dx.doi.org/10.3332/ecancer.2019.904 |
Ejemplares similares
-
PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues
por: Murthy, Pooja, et al.
Publicado: (2019) -
Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers
por: Dilawari, A, et al.
Publicado: (2008) -
The Changing Landscape of Breast Cancer: How Biology Drives Therapy
por: Friend, Sarah, et al.
Publicado: (2016) -
Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007) -
Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)